Do I Need an In-Person Visit?

One of the most common questions we hear from new patients is whether they'll need to physically show up to an office to start or continue Suboxone treatment. The honest answer is: it depends on the medication and the situation — not on some fixed rule that everyone has to follow. This article walks through the specific cases where an in-person visit genuinely matters, and the (much more common) cases where a video or phone visit does the job just as well.

When Telehealth Is Enough

For the large majority of patients being treated with sublingual buprenorphine (tablets or film, including Suboxone), Telehealth can cover the entire relationship — the intake evaluation, dose adjustments, check-ins, and routine refill visits. Current federal telemedicine flexibilities, most recently extended by the DEA and HHS through December 31, 2026, mean an in-person exam is not legally required before your first buprenorphine prescription. We cover the regulatory side of that in more detail in our article on telehealth eligibility (see "Can I Get Suboxone Through Telehealth?"), but the short version for this article is: the law currently allows it, and clinically, a video visit gives your provider what they need for most follow-up care — a conversation about how you're doing, review of symptoms or side effects, and a plan for your next refill.

When You'll Need to Come In: Extended-Release Injections

The clearest, most predictable case where an in-person visit is required has nothing to do with regulatory flexibilities and everything to do with how a specific medication is delivered. If you and your provider decide that a monthly extended-release buprenorphine injection — Sublocade or Brixadi — is the right fit for you, that injection has to be given in person by a healthcare provider. It cannot be prescribed for you to pick up and give to yourself.

This isn't a clinic policy — it's built into the FDA-approved prescribing information for both medications. Both drugs are distributed under Risk Evaluation and Mitigation Strategy (REMS) programs that specifically require the medication to go directly to a healthcare provider for administration, not to the patient.

Practically, this means that if injectable treatment is on the table for you, you should plan to build at least a monthly in-person appointment into your routine — even if your other check-ins happen by video.

Other Reasons an In-Person Visit Helps

Beyond injections, there are several situations where coming into the office — or being referred to one — is the more sensible clinical choice, even though it isn't legally mandatory:

• A physical exam is needed. If you're describing symptoms that are hard to assess over video — unusual pain, a wound, signs of infection, or something else your provider wants to see or feel directly — an in-person exam gives more reliable information than a camera can.
• Co-occurring health conditions. If you have other medical issues that need hands-on assessment alongside your addiction treatment (for example, cardiac symptoms, complicated withdrawal, or a condition that affects how buprenorphine should be dosed), your provider may recommend an office visit to evaluate you more thoroughly.
• A telehealth visit raises a concern. Sometimes something comes up in a video visit — a symptom, a lab result, or a change in your condition — that your provider wants to follow up on face-to-face before adjusting your treatment plan.
• You simply prefer it. Some patients feel more comfortable talking through sensitive topics, building trust with a new provider, or managing a new diagnosis in person. That preference is entirely valid, and it's reason enough on its own.

How This Works at Acorn TeleMAT

Acorn TeleMAT is built to give you both options, not to push you toward one. We have a physical office in Tustin, California, available by appointment for patients who need or prefer in-person care — including anyone starting or continuing Sublocade or Brixadi injections. For everyone else, or for patients anywhere in California who simply prefer the convenience, our Telehealth visits are available statewide for both initial evaluations and ongoing refill visits.

You're not locked into one path. Many patients start entirely on Telehealth and later decide an in-person visit makes sense — say, if they switch to a monthly injection — while others come in for an initial visit and then move most of their follow-up care to video. Your treatment plan can flex as your needs change.

Neither Option Is "Lesser" Care

It's worth saying clearly: choosing Telehealth doesn't mean you're getting a watered-down version of treatment, and needing an in-person visit doesn't mean something has gone wrong. The right visit type is a clinical and personal decision, not a ranking. Telehealth exists because for most buprenorphine care, it works — it removes travel time, scheduling friction, and access barriers without sacrificing the quality of the visit. In-person care exists because certain medications and certain situations genuinely call for a provider's hands-on evaluation. Good addiction medicine uses both tools appropriately, and that's exactly what we aim to do.

This article is for general educational purposes and isn't a substitute for individualized medical advice. Talk with your provider about which visit type is appropriate for your specific treatment plan.